Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea · Delayed Price · Currency is KRW

27,400

+800 (3.01%)

Apr 8, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			600.76B	637.71B	560.13B	561.85B	517.47B
Pharmaceuticals Growth			-5.80%	13.85%	-0.30%	8.58%	2.69%
Total			600.76B	637.71B	560.13B	561.85B	517.47B
Total Growth			-5.80%	13.85%	-0.30%	8.58%	2.69%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other			3.28B	5.05B	4.48B	4.94B	4.75B
Other Growth			-35.07%	12.88%	-9.42%	4.00%	-
South Korea			590.69B	623.12B	547.49B	545.30B	507.07B
South Korea Growth			-5.20%	13.81%	0.40%	7.54%	-
Japan			3.77B	8.86B	3.41B	4.43B	3.90B
Japan Growth			-57.42%	159.69%	-23.00%	13.78%	-
Southeast Asia			3.01B	-	-	-	-
China			-	677.34M	4.75B	7.17B	1.75B
China Growth			-	-85.75%	-33.74%	310.39%	-
Total			600.76B	637.71B	560.13B	561.85B	517.47B
Total Growth			-5.80%	13.85%	-0.30%	8.58%	-

Source: S&P Global Market Intelligence.